Abstract
Sepsis in humans is a difficult condition to treat and is often associated with a high mortality rate. In this study, we induced sepsis in rats using cecal ligation and puncture (CLP). In rats depleted of the complement factor C3, CLP led to very short survival times (about 4 days). Of the rats that underwent CLP ('CLP rats') that were C3-intact and treated with preimmune IgG, most (92%) were dead by 7 days. Blood neutrophils from these rats contained on their surfaces the powerful complement activation product C5a. This group had high levels of bacteremia, and their blood neutrophils when stimulated in vitro had greatly reduced production of H2O2, which is known to be essential for the bactericidal function of neutrophils. In contrast, when companion CLP rats were treated with IgG antibody against C5a, survival rates were significantly improved, levels of bacteremia were considerably reduced, and the H2O2 response of blood neutrophils was preserved. Bacterial colony-forming units in spleen and liver were very high in CLP rats treated with preimmune IgG and very low in CLP rats treated with IgG antibody against C5a, similar to values obtained in rats that underwent 'sham' operations (without CLP). These data indicate that sepsis causes an excessive production of C5a, which compromises the bactericidal function of neutrophils. Thus, C5a may be a useful target for the treatment of sepsis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
CD5L as a promising biological therapeutic for treating sepsis
Purified complement C3b triggers phagocytosis and activation of human neutrophils via complement receptor 1
References
Bone, R.C. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit. Care Med. 24, 163β172 (1996).
Nichols, R. et al. Risk of infection after penetrating abdominal trauma. N. Engl. J. Med. 311, 1065β1070 (1984).
Border, J.R. et al. The gut origin sepsis state in blunt multiple trauma (ISS=40) in the ICU. Ann. Surg. 206, 427β448 (1987).
Dinarello, C.A., Gelfand, J.A. & Wolff, S.M. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. J. Am. Med. Assoc. 269, 1829β1835 (1993).
Deitch, E.A. Animal models of sepsis and shock: a review and lessons learned. Shock 9, 1β11 (1997).
Wichtermann, K.A., Bauer, A.E. & Chaudry, I.H. Sepsis and shock β a review of laboratory models and a proposal. J. Surg. Res. 29, 189β201 (1980).
Nakae, H., Endo, S., Inada, K. & Yoshida, M. Chronological changes in the complement system in sepsis. Jpn. J. Surg. 26, 225β229 (1996).
Quezado, Z.M. et al. The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure. J. Exp. Med. 179, 569β578 (1994).
Kubens, B.S. & Opferkuch, W. in The Complement System (eds. Rother, K. & Till, G.O.) 469β487 (Springer-Verlag, Berlin, 1988).
Koehl, J. & Bitter-Suermann, D. in Anaphylatoxins. Complement in Health and Disease (eds. Whaley, K., Loos, M. & Weiler, J.M.) 299β324 (Kluwer Academic, London, 1993).
Klebanoff, S.J. Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes. Semin. Hematol. 12, 117β142 (1975).
Elsbach, P. & Weiss, J. Oxygen-dependent and oxygen-independent mechanisms of microbicidal activity of neutrophils. Immunol. Lett. 11, 159β163 (1983).
Wessels, M.R. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA 92, 11490β11494 (1995).
Fischer, M.B. et al. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J. Immunol. 159, 976β982 (1997).
May, J.E., Kane, M.A. & Frank, M.M. Host defense against bacterial endotoxemiaβcontribution of the early and late components of complement to detoxification. J. Immunol. 109, 893β895 (1972).
Schumacher, W.A., Fantone, J.C., Kunkel, S.E., Webb, R.C. & Lucchesi, B.R. The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculature in vitro and in vivo. Agents Actions 34, 345β349 (1991).
Ward, P.A. & Becker, E.L. The deactivation of rabbit neutrophils by chemotactic factor and the nature of activatable esterase. J. Exp. Med. 127, 693β709 (1968).
Solomkin, J.S., Jenkins, M.K., Nelson, R.D., Chenoweth, D. & Simmons, R.L. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation. Surgery 90, 319β327 (1981).
Mulligan, M.S. et al. Requirement and role of C5a in acute inflammatory lung injury in rats. J. Clin. Invest. 98, 503β512 (1996).
Hill, J.H. & Ward, P.A. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J. Exp. Med. 133, 885β900 (1971).
Alexander, J.W. et al. A comparison of immunologic profiles and their influence on bacteremia in surgical patients with a high risk of infection. Surgery 86, 84β104 (1979).
Mohr M et al. Effects of anti-C5a monoclonal antibodies on oxygen use in a porcine model of severe sepsis. Eur. J. Clin. Invest. 28, 227β234 (1998).
Stevens, J.H. et al. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J. Clin. Invest. 77, 1812β1816 (1986).
Johnson, K.J. & Ward, P.A. Protective function of C6 in rabbits treated with bacterial endotoxin. J. Immunol. 106, 1125β1127 (1971).
HΓΆpken, U.E., Lu, B., Gerard, N.P. & Gerard, C. The C5a chemoattractant receptor mediates mucosal defense to infection. Nature 383, 86β89 (1996).
Naik, N., Giannini, E., Brouchon, L. & Boulay, F. Internalization and recycling of the C5a anaphylatoxin receptor: evidence that the agonist-mediated internalization is modulated by phosphorylation of the C-terminal domain. J. Cell Science. 110, 2381β2390 (1997).
Giannini, E. & Boulay, F. Phosphorylation, dephosphorylation, and recycling of the C5a receptor in differentiated HL60 cells. J. Immunol. 154, 4055β4064 (1995).
Bock, D. et al. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization. Eur. J. Immunol. 27, 1522β1529 (1997).
Van Epps, D.E., Simpson, S., Bender, J.G. & Chenoweth, D.E. Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes. J Immunol 144, 1062β1068 (1990).
Van Epps, D.E., Simpson, S.J. & Johnson, R. Relationship of C5a receptor modulation to the functional responsiveness of human polymorphonuclear leukocytes to C5a. J. Immunol. 150, 246β252 (1993).
Czermak, B.J. et al. Mechanisms of enhanced lung injury during sepsis. Am J Path 154, 1057β1065 (1999).
Olson, L.M., Moss, G.S., Baukus, O. & Das Gupta, T.K. The role of C5 in septic lung injury. Ann. Surg. 202, 771β776 (1985).
Rothermel, E., Rolf, O., GΓΆtze, O. & Zwirner, J. Nucleotide and corrected amino acid sequence of the functional recombinant rat anaphylatoxin C5a. Biochim. Biophys. Acta 1351, 9β12 (1997).
Rights and permissions
About this article
Cite this article
Czermak, B., Sarma, V., Pierson, C. et al. Protective effects of C5a blockade in sepsis. Nat Med 5, 788β792 (1999). https://doi.org/10.1038/10512
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/10512
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
-
Cronobacter sakazakii Infection in Early Postnatal Rats Impaired Contextual-Associated Learning: a Putative Role of C5a-Mediated NF-ΞΊΞ² and ASK1 Pathways
Journal of Molecular Neuroscience (2021)
-
Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis
Seminars in Immunopathology (2021)
-
Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis
Nature Nanotechnology (2020)
-
Complement levels in patients with bloodstream infection due to Staphylococcus aureus or Gram-negative bacteria
European Journal of Clinical Microbiology & Infectious Diseases (2020)
-
Inter-Ξ±-inhibitor Ameliorates Endothelial Inflammation in Sepsis
Lung (2019)
